rss
Br J Ophthalmol 82:476-479 doi:10.1136/bjo.82.5.476
  • Original Article
    • Clinical science

Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia

Table 2

Results

No Partial response Complete response Local control Metastasis melanoma Death Cryotherapy symblepharon Pretreatment vision Most recent vision Side effects Follow up (months)
Short term Long term
1 adjuvant adjuvant yes none No none 20 20 KC None 46
2 yes no no yes No none 25 prosthesis KC None 42
3 adjuvant adjuvant yes none No yes 40 30 KC None 40
4 adjuvant adjuvant yes none No none 20 20 KC None 37
5 adjuvant adjuvant yes none No none 25 25 KC None 32
6 no yes yes none CLL no cryotherapy 30 30 KC Corneal haze 26
7 adjuvant adjuvant yes none No none 20 20 KC None 24
8 adjuvant adjuvant yes none No none 20 20 KC None 21
9 no yes no none No no cryotherapy 20 20 KC None 12
10 yes no yes none No no cryotherapy 32 200† KC None‡  6
Mean 29

  • ↵Subconjunctival recurrence; †cataract progression;‡cataract not thought due to MMC. KC = keratoconjunctivitis.

This Article

  1. Abstract
  2. Full text
  3. PDF

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.